Therapeutic Exercise for Rotator Cuff Tendinopathy / Subacromial Pain Syndrome - Outcomes and Mechanisms
Launched by UNIVERSITY OF SOUTHERN CALIFORNIA · Jun 6, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating how therapeutic exercise can help people with rotator cuff tendinopathy and subacromial pain syndrome, which are common causes of shoulder pain. The study aims to understand why some patients respond well to exercise while others do not, especially looking at how the brain may influence pain and recovery. Researchers will use brain imaging to learn more about these mechanisms and identify factors that predict a positive response to exercise.
To participate in this study, individuals aged 18 to 45 with rotator cuff tendinopathy and a pain level of at least 3 out of 10 may be eligible. Participants will need to complete some tests to confirm their diagnosis and must not have certain medical conditions or a history of shoulder surgery. Those who join the trial can expect to engage in therapeutic exercise sessions and contribute to important research that may improve treatment options for shoulder pain.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. the clinical diagnosis for RC tendinopathy will be made with positive 3 of 5 tests: Hawkins-Kennedy, Neer, painful arc, empty can, external rotation resistance test
- • 2. pain ≥ 3/10 on a numeric pain rating scale
- • 3. age: 18 - 45 years
- • 4. Participant must read, sign and date the appropriate Informed consent document.
- • 5. Participant BMI ≤ 30
- Exclusion Criteria:
- • 1. Insufficient ability to comprehend and complete the questionnaires,
- • 2. Inability to attend sessions,
- • 3. Prior surgery of shoulder, neck or thoracic spine,
- • 4. Primary complaint of neck or thoracic pain,
- • 5. Diagnosis of cervical spinal stenosis,
- • 6. Any serious spinal and shoulder pathology: infections, arthrosis, rheumatic disorders, acute fractures, shoulder dislocation, osteoporosis, or tumors,
- • 7. Central Nervous System involvement, to include hyperreflexia, sensory disturbances in the hand, intrinsic muscle wasting of the hands, unsteadiness during walking, nystagmus, loss of visual acuity, impaired sensation of the face, altered taste, the presence of pathological reflexes (i.e. positive Hoffman and/or Babinski reflexes,
- • 8. two or more neurologic signs of nerve root compression to include myotomal weakness, positive muscle stretch reflex, and dermatomal sensory loss,
- • 9. any shoulder or arm pain with cervical spine tests of Spurling's Test, cervical rotation to the ipsilateral side, or axial compression test, or
- • 10. primary adhesive capsulitis defined by passive range of motion loss \>50% as compared bilaterally of shoulder external rotation, internal rotation, or elevation.
- • 11. Has a device or other condition that is not safe for MRI, including pacemakers.
About University Of Southern California
The University of Southern California (USC) is a prestigious research institution located in Los Angeles, California, known for its commitment to advancing knowledge and innovation in various fields, including medicine and health sciences. As a clinical trial sponsor, USC leverages its extensive resources, interdisciplinary expertise, and state-of-the-art facilities to conduct cutting-edge research aimed at improving patient outcomes and public health. The university fosters collaboration among its diverse faculty and students, ensuring a dynamic environment for the development and implementation of clinical studies that adhere to the highest ethical and scientific standards. Through its clinical trials, USC aims to contribute to the advancement of medical science and the translation of research findings into practical applications that benefit communities locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Los Angeles, California, United States
Patients applied
Trial Officials
Lori A Michener, PT, ATC, PhD
Principal Investigator
University of Southern California
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials